Greg D. Carmichael
Greg D. Carmichael's purchase track record
Greg D. Carmichael has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/3/2024 | EHC | $167K | +11.6% | +19.3% | +11.7% |
| 10/31/2022 | EHC | $100K | +12.2% | +18.7% | +7.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Fifth Third Bancorp: Infrastructure Optimism and Q3 Earnings Outlook. Fifth Third Wealth Advisors' CIO Chris Osmond is bullish on infrastructure, pointing to potential opportunities in the sector. Additionally, growth in net interest income and lower expenses are expected to support the company's upcoming third-quarter earnings. The stock's 5.14% dividend yield remains a key focus ahead of the report.
Transaction History
| EHC | ▲ Buy | Grant | 29 | $0 | 7/15/2026 | View on chart |
| EHC | ▲ Buy | Grant | 1,634 | $0 | 5/7/2026 | View on chart |
| EHC | ▲ Buy | Grant | 27 | $0 | 4/15/2026 | View on chart |
| EHC | ▲ Buy | Grant | 28 | $0 | 1/15/2026 | View on chart |
| EHC | ▲ Buy | Grant | 23 | $0 | 10/15/2025 | View on chart |
| EHC | ▲ Buy | Grant | 24 | $0 | 7/15/2025 | View on chart |
| EHC | ▲ Buy | Grant | 1,424 | $0 | 5/1/2025 | View on chart |
| EHC | ▲ Buy | Grant | 23 | $0 | 4/15/2025 | View on chart |
| EHC | ▲ Buy | Grant | 25 | $0 | 1/15/2025 | View on chart |
| EHC | ▲ Buy | Grant | 24 | $0 | 10/15/2024 | View on chart |
| EHC | ▼ Sell | Other | 7 | $608 | 7/15/2024 | View on chart |
| EHC | ▲ Buy | Grant | 24 | $0 | 7/15/2024 | View on chart |
| EHC | ▲ Buy | Open Market | 2,000 | $167K | 5/3/2024 | View on chart |
| EHC | ▲ Buy | Grant | 1,978 | $0 | 5/2/2024 | View on chart |
| EHC | ▼ Sell | Other | 3 | $244 | 4/15/2024 | View on chart |
| EHC | ▲ Buy | Grant | 21 | $0 | 4/15/2024 | View on chart |
| EHC | ▼ Sell | Other | 4 | $275 | 1/16/2024 | View on chart |
| EHC | ▲ Buy | Grant | 24 | $0 | 1/16/2024 | View on chart |
| EHC | ▲ Buy | Grant | 27 | $0 | 10/16/2023 | View on chart |
| EHC | ▲ Buy | Grant | 25 | $0 | 7/17/2023 | View on chart |
| EHC | ▲ Buy | Grant | 2,385 | $0 | 5/4/2023 | View on chart |
| EHC | ▲ Buy | Grant | 22 | $0 | 4/17/2023 | View on chart |
| FITB | ▼ Sell | Tax Withholding | 8,669 | $320K | 2/17/2023 | View on chart |
| FITB | ▼ Sell | Tax Withholding | 7,370 | $270K | 2/16/2023 | View on chart |
| FITB | ▼ Sell | Tax Withholding | 60,001 | $2.2M | 2/15/2023 | View on chart |
| FITB | ▲ Buy | Grant | 139,170 | $0 | 2/15/2023 | View on chart |
| FITB | ▲ Buy | Grant | 124,639 | $0 | 2/14/2023 | View on chart |
| FITB | ▼ Sell | Tax Withholding | 6,159 | $229K | 2/12/2023 | View on chart |
| EHC | ▲ Buy | Grant | 22 | $0 | 1/17/2023 | View on chart |
| EHC | ▲ Buy | Open Market | 1,830 | $100K | 10/31/2022 | View on chart |
| EHC | ▲ Buy | Grant | 27 | $0 | 10/17/2022 | View on chart |
| EHC | ▲ Buy | Grant | 50 | $0 | 7/20/2022 | View on chart |
| EHC | ▲ Buy | Grant | 2,226 | $0 | 5/5/2022 | View on chart |
| FITB | ▼ Sell | Open Market | 50,000 | $2.0M | 4/21/2022 | View on chart |
| EHC | ▲ Buy | Grant | 20 | $0 | 4/18/2022 | View on chart |
| FITB | ▼ Sell | Tax Withholding | 9,039 | $436K | 2/17/2022 | View on chart |
| FITB | ▲ Buy | Grant | 132,626 | $0 | 2/16/2022 | View on chart |
| FITB | ▼ Sell | Tax Withholding | 59,914 | $2.8M | 2/16/2022 | View on chart |
| FITB | ▲ Buy | Grant | 51,032 | $0 | 2/16/2022 | View on chart |
| FITB | ▼ Sell | Tax Withholding | 9,780 | $475K | 2/11/2022 | View on chart |
| FITB | ▼ Sell | Open Market | 67,687 | $3.3M | 2/9/2022 | View on chart |
| FITB | ▲ Buy | Option Exercise | 141,447 | $2.3M | 2/7/2022 | View on chart |
| FITB | ▼ Sell | Tax Withholding | 88,123 | $4.3M | 2/7/2022 | View on chart |
| FITB | ▼ Sell | Tax Withholding | 11,835 | $560K | 2/4/2022 | View on chart |
| EHC | ▲ Buy | Grant | 23 | $0 | 1/18/2022 | View on chart |
| FITB | ▼ Sell | Gift | 23,450 | $0 | 12/17/2021 | View on chart |
| EHC | ▲ Buy | Grant | 21 | $0 | 10/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Encompass Health Sets Q3 2026 Earnings Call Date
Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.
Encompass Health Sets Q3 2026 Earnings Call Date. Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.